These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11781441)

  • 1. Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease.
    Brandstädter D; Oertel WH
    Neurology; 2002 Jan; 58(1):160-1. PubMed ID: 11781441
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Lannon MC; Friedman JH; Abbott BP
    Mov Disord; 2000 May; 15(3):579-81. PubMed ID: 10830427
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease.
    Dewey RB; O'Suilleabhain PE
    Neurology; 2000 Dec; 55(11):1753-4. PubMed ID: 11113242
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine for drug-induced psychosis in Parkinson's disease.
    Brown TM
    N Engl J Med; 1999 Aug; 341(6):456. PubMed ID: 10438274
    [No Abstract]   [Full Text] [Related]  

  • 5. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Friedman JH; Jacques C; Rosenfeld M
    Mov Disord; 1999 May; 14(3):484-7. PubMed ID: 10348474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease.
    Morgante L; Epifanio A; Spina E; Di Rosa AE; Zappia M; Basile G; La Spina P; Quattrone A
    Neurol Sci; 2002 Sep; 23 Suppl 2():S89-90. PubMed ID: 12548358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [No rebound psychosis in a case of switching from clozapine to quetiapine].
    Walther S; Baciu D
    Psychiatr Prax; 2006 Mar; 33(2):93-4. PubMed ID: 16502388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurochemical mechanism of rebound psychosis in Parkinson's disease.
    Papapetropoulos S; Mash DC
    Mov Disord; 2005 Apr; 20(4):515. PubMed ID: 15747367
    [No Abstract]   [Full Text] [Related]  

  • 9. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.
    Fernandez HH; Trieschmann ME; Burke MA; Friedman JH
    J Clin Psychiatry; 2002 Jun; 63(6):513-5. PubMed ID: 12088163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.
    Menza MM; Palermo B; Mark M
    Ann Clin Psychiatry; 1999 Sep; 11(3):141-4. PubMed ID: 10482124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis].
    Kodama R; Morita S; Miwa H; Kondo T
    No To Shinkei; 2003 May; 55(5):413-7. PubMed ID: 12833883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine for l-dopa-induced psychosis in PD.
    Weiner WJ; Minagar A; Shulman LM
    Neurology; 2000 Apr; 54(7):1538. PubMed ID: 10751276
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Parkinson Study Group
    N Engl J Med; 1999 Mar; 340(10):757-63. PubMed ID: 10072410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular ectopics during crossover of atypical antipsychotics.
    O'Shea M; Sazhin V; Collins A
    Aust N Z J Psychiatry; 2003 Dec; 37(6):773-4. PubMed ID: 14636396
    [No Abstract]   [Full Text] [Related]  

  • 15. Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
    Ruggieri S; De Pandis MF; Bonamartini A; Vacca L; Stocchi F
    Clin Neuropharmacol; 1997 Jun; 20(3):204-9. PubMed ID: 9197942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of quetiapine in Parkinson's patients with psychosis.
    Targum SD; Abbott JL
    J Clin Psychopharmacol; 2000 Feb; 20(1):54-60. PubMed ID: 10653209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses.
    Potvin S; Stip E; Roy JY
    Int Clin Psychopharmacol; 2003 May; 18(3):121-32. PubMed ID: 12702890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios.
    Hubbard D; Hacksell U; McFarland K
    Behav Pharmacol; 2013 Oct; 24(7):628-32. PubMed ID: 23969614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: a case report.
    Stephani C; Trenkwalder C
    Mov Disord; 2010 Apr; 25(6):790-1. PubMed ID: 20198646
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing atypical antipsychotic treatment strategies in the elderly.
    Katz IR
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S272-7. PubMed ID: 15541168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.